Home › Studies › PRJEB61942
PRJEB61942 ERP147020

Gut microbiota during anti-PD-1 therapy in melanoma, Italy

Longitudinal study of the gut microbiota during anti-pd1 immunotherapy in melanoma patients.

65 stool samples from advanced melanoma patients in Italy (Milan and Naples), collected longitudinally during anti-PD-1 immune checkpoint inhibitor therapy to study gut microbiota changes. machine-written summary

65 samples · 65 runs · IT · Adult · 2024 · 8.20 Gbp / sample

Sources
✓Sequence archive 390○Abstract / description○Full text○Supplementary tables–External resources–User contribution–Human verified

Checked this project's papers and archive records yourself? Mark it human-verified.

what each source gave
✓ Sequence archive390 sample values (collection date, country, health condition, health condition detail, intervention, subject id)
○ Abstract / descriptionread; no usable statement
○ Full textread; no usable statement or table · PMC11629153
○ Supplementary tablesfiles read; no table could be matched to the samples
– External resourcesnot covered by the external resources we ingest
– User contributionnothing uploaded yet
– Human verifiednot yet checked by a person · I checked this project — verify it
Samples at a glance
1 country
Age
adult65
Condition
other_cancer65
Country
IT65
Body site
primary65
Collected 2018–2020
2018: 37 samples2019: 27 samples2020: 1 samples20182020
Sequencing depth per sample · this project all projects
all projects, 0–0.03 Gbp: 25,080 samples (4 %)all projects, 0.03–0.1 Gbp: 17,066 samples (3 %)all projects, 0.1–0.3 Gbp: 29,179 samples (5 %)all projects, 0.3–1 Gbp: 47,044 samples (8 %)all projects, 1–3 Gbp: 124,983 samples (22 %)all projects, 3–10 Gbp: 253,728 samples (44 %)this project, 3–10 Gbp: 52 samplesall projects, 10–30 Gbp: 72,533 samples (13 %)this project, 10–30 Gbp: 13 samplesall projects, 30–100 Gbp: 3,024 samples (1 %)all projects, 100–300 Gbp: 106 samples (0 %)all projects, ≥ 300 Gbp: 9 samples (0 %)project median 8.20 Gbp per sample0130Gbp
Sampling design and relatedness

longitudinal — not resolved

11 of 14 people sampled more than once (62 samples; median 6, up to 9 per person).

How longitudinal and relatedness information is derived

Community composition
Bifidobacterium 12.3%Faecalibacterium 9.0%Bacteroides 6.9%Ruminococcoides 5.2%Blautia_A 4.4%Gemmiger 3.8%Phocaeicola 3.4%Collinsella 3.2%Alistipes 3.2%Roseburia 3.1%Streptococcus 2.6%Vescimonas 1.4%not assigned to a genus 4.1%other genera 37.4%

Genera, mean relative abundance over 63 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).

Field coverage
fieldsamplescoverageR1R2R3R4
age_category65 100%
country65 100%65
health_condition65 100%65
subject_id65 100%65
collection_date65 100%65
health_condition_detail65 100%65
intervention65 100%65
Papers (1)
  • Longitudinal analysis of the gut microbiota during anti-PD-1 therapy reveals stable microbial features of response in melanoma patients. 2024 PMID 39481388 PMC11629153 unsure
Details
Archive description

The microbiome immune oncology (MIO) studies are two separate observational cohort studies recruiting subjects in parallel in the Milan. (MIO-IEO) and Naples (MIO-FGP) since 2018. These cohorts of advanced melanoma patients were used to study changes in the gut microbiome of patients during treatment with monoclonal antibodies targeting the immune checkpoint protein PD-1. We used 16S rRNA and shotgun metagenomic sequencing of stool samples collected over 13 months from the starting of the therapy and compared them with 9 publicly available external cohorts.

How this project entered the registry

Classified as human gut / stool shotgun DNA metagenome of adult by deterministic_prior with confidence 0.90. Assay shotgun_dna.

  • host external_curation.infant_catalog · “infant triage reason_code age_adult_only”
  • body site study.title · “study of the gut microbiota during anti-pd1”
  • body site study.description · “changes in the gut microbiome of patients”
  • life stage external_curation.infant_catalog · “infant triage reason_code age_adult_only”
Evidence examples (one per field × route)
samplefieldvaluerouteconf.sourcequote
SAMEA116143071collection_date2018R10.90biosample.attribute:collection_date2018
SAMEA116143071countryITR10.90sample.attr.geographic_location_country_and_or_seaItaly
SAMEA116143071health_conditionother_cancerR10.85biosample.attribute:descriptionfecal sample from melanoma patient undergoing anti-PD1
SAMEA116143071health_condition_detailfecal sample from melanoma patient undergoing anti-PD1R10.85biosample.attribute:descriptionfecal sample from melanoma patient undergoing anti-PD1
SAMEA116143071interventiondrug_therapyR10.85biosample.attribute:descriptionfecal sample from melanoma patient undergoing anti-PD1
SAMEA116143071subject_idIEO-001R10.70sample.name_rule:aliasIEO-001-WGS_1144
Sequencing

65 runs over 65 samples · mean 8.63 Gbp per run (median 8.20 Gbp, total 560.68 Gbp; 65 runs with a base count) · layout PAIRED 65 · platform ILLUMINA 65 · models Illumina NovaSeq 6000 (65) · 97% of runs with a Sandpiper profile · first public 2024-10-23

Authors (32)

Macandog ADG first · Catozzi C · Capone M · Nabinejad A · Nanaware PP · Liu S · Vinjamuri S · Stunnenberg JA · Galiè S · Jodice MG · Montani F · Armanini F · Cassano E · Madonna G · Mallardo D · Mazzi B · Pece S · Tagliamonte M · Vanella V · Barberis M · Ferrucci PF · Blank CU · Bouvier M · Andrews MC · Xu X · Santambrogio L · Segata N · Buonaguro L · Cocorocchio E · Ascierto PA · Manzo T · Nezi L last

Downloads

PRJEB61942.csv.gz (2.5 KB) · parquet (72.3 KB) — all 65 samples, every field with route and confidence · PRJEB61942_determinations.csv.gz (3.2 KB) — 390 evidence rows

Samples (65 · every field this project has values for · hover a cell for its source)
Loading the sample table…